Back
EyePoint Pharmaceuticals Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
64
EYPT
EyePoint Pharmaceuticals
Last Price:
9.46
Seasonality Move:
-10.5%
Sell
19
ITCI
Intra-Cellular Therapies
Last Price:
75.76
Seasonality Move:
0.51%
Buy
64
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $8.91. The Score for EYPT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $74.68. The Score for ITCI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $8.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing slight selling pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $74.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 53.32 | Buy |
Chaikin Money Flow: | -111904 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.02 - 9.02) | Buy |
Bollinger Bands (100): | (7.51 - 12.45) | Sell |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 50.66 | Buy |
Chaikin Money Flow: | -224656 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.2 - 75.56) | Buy |
Bollinger Bands (100): | (68.21 - 76.69) | Buy |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.63 | Buy |
20-day SMA: | 8.68 | Buy |
50-day SMA: | 8.89 | Buy |
200-day SMA: | 16.42 | Sell |
8-day EMA: | 8.71 | Buy |
20-day EMA: | 8.63 | Buy |
50-day EMA: | 9.07 | Sell |
200-day EMA: | 12.38 | Sell |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 74.79 | Sell |
20-day SMA: | 74.06 | Buy |
50-day SMA: | 75.79 | Sell |
200-day SMA: | 70.43 | Buy |
8-day EMA: | 74.7 | Sell |
20-day EMA: | 74.52 | Buy |
50-day EMA: | 74.32 | Buy |
200-day EMA: | 69.8 | Buy |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
EyePoint Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |